The document outlines various skin disorders, their clinical manifestations, management strategies, and potential complications. It covers bacterial infections, herpes simplex, fungal infections, psoriasis, skin trauma, pressure ulcers, and skin cancer, detailing diagnostic methods and treatment options. Additionally, it highlights the importance of monitoring and managing risks associated with these conditions to improve patient outcomes.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0 ratings0% found this document useful (0 votes)
1 views13 pages
CH 50 Skin Disorders
The document outlines various skin disorders, their clinical manifestations, management strategies, and potential complications. It covers bacterial infections, herpes simplex, fungal infections, psoriasis, skin trauma, pressure ulcers, and skin cancer, detailing diagnostic methods and treatment options. Additionally, it highlights the importance of monitoring and managing risks associated with these conditions to improve patient outcomes.
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 13
CH 50: Skin Disorders
Type Clinical Manifestation Management Complications
Bacterial Skin Infection *See Table 50.2* Blood C/S Skin and soft tissue infection Fever CT Overuse of Abx Tachycardia CBC Necrotizing soft tissue Pain Needle bx infection Disorientation Punch bx SSI Lethargy Cellulitis Hypotension Quantitative tissue bx Ischemia invasive test, tissue below Tissue necrosis surface of wound obtained and Sepsis sent for quantitative gram Fournier’s. gangrene stain and culture See table 50.1 Herpes Simplex Primary: first time infected HSV1 or HSV 2 lab analysis Quality of life r/t stress of dx individual -Virological testing of GH Direct contact w/individual mucocutaneous (region of -Pt feel isolated, devastated who is asymptomatic, in a body where mucosa and embarrassed prodromal stage of disease or transitions into skin) lesions or -Pregnancy complication of has active/genital infections, ulcers disseminated neonatal herpes secretions or lesions -Cytological tzanck’s smear (C-Sections recommended) Fever (examines skin scrapings Malaise smeared onto slide) Myalgia -Cervical pap smear Anorexia -Serological type specific Irritability glycoproteim G-based assay Cervical/Inguinal Partner w/GH, person lymphadenopathy presenting for STI testing Lesions (lip, face, mucous w/hx of multiple sex partners, membranes of mouth, person w/HIV or homosexual pharynx, genitals) men Secondary: recurrent HSV Suppressive therapy: antiviral: infections occur following acyclovir, valacyclovir, exogenous or endogenous famciclovir (for GH) trigger that reactive the dormant virus UV light exposure Febrile illness Stress Fungal Infections Dermatophytes (aerobic) Antifungal agents are primary Proliferate (esp in critically ill reproduce with spores H&P and immunocompromised) Yeast KOH microscopy hyphae candida Rashes confirm dx Tx pt at greatest risk Vesicles Wood’s lamp UV light w/antifungal medications to Pustules held close to skin in darkened reduce morbidity from room, helpful in dx tinea candidemia versicolor (fluoresces pale -Use of corticosteroids or yellow to white) immunosuppressive Fungal culture medications, abx use, Histological evaluation parenteral nutrition, presence of invasive CVC Psoriasis Lifelong inflammatory No lab test specific Risk of developing other disorder characterized by Dx based on pt’s clinical disease (CA, CV disease, exacerbation and remissions manifestation Crohn’s, diabetes, metabolic of raised, scaling, ESR high syndrome, uveitis, liver erythematous plaques Goal of tx: reduce clinical disease) Plaques seen on the elbow, manifestations, control -Basal cell carcinoma knees, legs, palms, soles of disease, improve quality of -Squamous cell carcinoma r/t feet, scalp, trunk, face life exposure during phototherapy Pitting (onycholysis lifting See table 50.5 -Systemic infections of nail away from nail bed) Topical creams and ointments, Splinter hemorrhages under UV light therapy, systemic nail medication *medications (Li, B-blockers, indomethacin) Skin Trauma Edema H&P Risk for infection Erythema Immunization hx erythema, increased Heat *Tetanus temperature surrounding Pain ABI: ratio of systolic BP tissue, odor, purulent drainage, Necrotic tissue obtained at the ankle and in increased swelling, increased *See table 50.6 the arm is sensitive, non- pain, fever invasive indicator of arterial Depth of injury damage perfusion to LE underlying structure of Nutritional status muscle, tendon, bone and MUST scale (malnutrition nerve universal screening tool) Infection wound management (C/S of wound by swabbing or bx) Assessment includes overall health and nutritional status, skin integrity, mobility, hydration of status Debridement methods: see table 50.9 Pressure Ulcers Occurs in pt w/limited Braden scale Infection mobility and bed ridden 15-18: mild Swab cultures Localized injury to skin and/or 13-14: moderate Punch bx w/culture identify underlying tissue (over. Bony 10-12: high bacteria in deeper tissues such prominence) <9: very high risk as muscle and bone Redness Nutritional assessment: see *Osteomyelitis evaluate Blanching table 50.12 w/x-ray, CT, or MRI bone Skin breakdown CRP exposed pt is dx clinically ESR w/osteomyelitis Vigilant monitoring (fever, Wounds contaminated w/fecal increased WBC,) or urine -Colostomy (temporary diverting) once site healed, r-anastomosed at pt’s request Skin Cancer See box 50.5 Dependent on size, location, Financial concerns for Actinic keratosis: recurrence, current health families during tx precancerous lesions, status Infections proliferate in epidermis Surgical excision Psychosocial -No tx squamous cell Curettage and carcinoma electrodesiccation Clinical features: Skin-colored Mohs’ micrographic sx to reddish brown macules, Photodynamic therapy papules, or plaques; range Cryotherapy from a few millimeters up to 2 Radiotherapy cm; usually occur as multiple Chemotherapy (topical) lesions Body distribution: Sun- exposed areas (particularly cheeks, temples, forehead, anterior and posterior neck, ears, backs of hands, and forearms) Clinical course: May begin as erythematous, scaly plaques that exfoliate with toweling off or the rubbing of clothes during the day; induration at the base, cutaneous horn, ulceration, or pain may indicate transformation to squamous cell carcinoma. Squamous cell carcinoma: most attributed to exposure to UVB over extended period of time Clinical features: Crusted papules and plaques that can become indurated and ulcerated. Larger lesions can become painful and bleed. -Can arise from chronically open wounds, burn scars, or leg ulcers because of chronic inflammation. Body distribution: Sun- exposed skin, especially the top of the head, neck, and lips Clinical course: Can invade fatty tissue beneath the dermis and spread via the lymph nodes to other parts of the body (although, this is not that common); recurrence rate within 3 years is 18%. Basal cell carcinoma: arise from basement membrane of epidermis (rarely metastaticSignificantly damage tissue secondary to large excision) Clinical features: Pearly, translucent, flesh-colored papules; superficial telangiectasias (broken blood vessels) are usually visible; may have rolled edges or ulcerations Body distribution: Sun- exposed areas, especially head, neck, and trunk Clinical course: Usually not metastatic but can become locally invasive; recurrence rate after excision is 44% in 3 years Malignant melanoma: most serious, originates from melanocytes found in basement membrane of epidermis -ABCDE -ANYWHERE on body, esp existing moles, upper back, lower legs, soles of feet, palms of hands and dark-skinned individuals Reconstructive Surgery ABI Ratio (Systolic BP/BP at ankle or arm) Braden scale